Kim Dong Hwan, Choi Joon-Il
Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Ultrasonography. 2021 Jan;40(1):45-56. doi: 10.14366/usg.20067. Epub 2020 Jul 25.
Although the overall prognosis of patients with hepatocellular carcinoma (HCC) remains poor, curative treatment may improve the survival of patients diagnosed at an early stage through surveillance. Accordingly, ultrasonography (US)-based HCC surveillance programs proposed in international society guidelines are now being implemented and regularly updated based on the latest evidence to improve their efficacy. Recently, other imaging modalities such as magnetic resonance imaging have shown potential as alternative surveillance tools based on individualized risk stratification. In this review article, we describe the current status of US-based surveillance for HCC and summarize the supporting evidence. We also discuss alternative surveillance imaging modalities that are currently being studied to validate their diagnostic performance and cost-effectiveness.
尽管肝细胞癌（HCC）患者的总体预后仍然很差，但通过监测进行的根治性治疗可能会提高早期诊断患者的生存率。因此，国际社会指南中提出的基于超声（US）的HCC监测计划目前正在实施，并根据最新证据定期更新，以提高其有效性。最近，其他成像方式，如磁共振成像，已显示出作为基于个体风险分层的替代监测工具的潜力。在这篇综述文章中，我们描述了基于US的HCC监测的现状，并总结了支持证据。我们还讨论了目前正在研究以验证其诊断性能和成本效益的替代监测成像方式。
